• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.20% Nasdaq Up0.41%

    aTyr Pharma Inc. (LIFE)

    11.59 Up 0.04(0.35%) Oct 9, 4:00PM EDT
    ProfileGet Profile for:
    aTyr Pharma Inc.
    3545 John Hopkins Court
    Suite 250
    San Diego, CA 92121
    United States - Map
    Phone: 858-731-8389
    Fax: 858-731-8394
    Website: http://www.atyrpharma.com

    Index Membership:N/A
    Full Time Employees:49

    Business Summary 

    aTyr Pharma, Inc. engages in the discovery and clinical development of protein based therapeutics for patients suffering from severe and rare diseases. The company is developing Resolaris, which is in Phase Ib/II clinical trials in adult patients with facioscapulohumeral muscular dystrophy, a rare genetic myopathy with an immune component. Its products pipeline also includes Resolaris for treatment of patients with early onset facioscapulohumeral muscular dystrophy, a rare genetic myopathy with an immune component and limb-girdle muscular dystrophies, as well as rare pulmonary diseases with an immune component. In addition, the company is developing iMod.Fc, a preclinical immuno-modulatory domain program. The company was founded in 2005 and is headquartered in San Diego, California.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on aTyr Pharma Inc.

    Corporate Governance 
    aTyr Pharma Inc.’s ISS Governance QuickScore as of Feb 1, 2014 is 6. The pillar scores are Audit: 1; Board: 4; Shareholder Rights: 4; Compensation: 8.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Dr. John D. Mendlein Ph.D., J.D., 55
    Exec. Chairman and Chief Exec. Officer
    Dr. Paul R. Schimmel Ph.D., 74
    Founder, Director and Member of Compensation Committee
    Dr. David M. Weiner M.D., 50
    Chief Medical Officer
    Xiang-Lei Yang Ph.D.,
    Mr. Stan Blackburn ,
    Principal Financial and Accounting Officer
    Ms. Marcy Graham , 48
    VP of Investor Relations & Corp. Communications
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders